^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Burkitt Lymphoma |
| Drug: | methotrexate (THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor) |
| Regimen: | (ifosfamide + Rituxan (rituximab) + cytarabine + etoposide IV) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Burkitt lymphoma: suggested treatment regimens…second-line therapy…other recommended regimens…RIVAC (rituximab, ifosfamide, cytarabine, etoposide); intrathecal methotrexate if have not received previously
